The FDA approved etripamil (Cardamyst) nasal spray for at-home treatment of paroxysmal supraventricular tachycardia (PSVT), maker Milestone Pharmaceuticals announced. The rapid-acting L-type calcium ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved a rapid-acting nasal spray for the treatment of acute symptomatic paroxysmal supraventricular ...

The US Food and Drug Administration has approved etripamil nasal spray (Cardamyst) for adults with acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT), drugmaker Milestone ...

CARDAMYST nasal spray is a novel and rapid-acting calcium channel blocker delivered when needed to treat often highly symptomatic and unpredictable episodes of PSVT. With CARDAMYST, adults with PSVT ...

Matt Nelson is an automotive journalist with nearly a decade of experience in all things cars. He's spent years working at dealerships in sales, finance, and service. He's since traded in his pens and ...

Axcelis Technologies, Inc. and Veeco Instruments Inc. are merging in a $4.4 billion all-stock deal to create a diversified semiconductor equipment company. The merger aims to broaden product offerings ...

This post was paid for by an advertiser. The Herald-Dispatch newsroom was not involved in its creation. Do EMTs really need ACLS certification? It’s a common question, especially for those starting to ...

Every spring, Sweden’s moose head north to their lush, green, summer grazing pastures. To reach their intended destination, dozens must swim across the scenic Ångerman River—and, as they do, they’re ...

A lot of car manufacturers have a performance division, and Ford is no exception. SVT is a special division of Ford that's focused on creating high-performance and sometimes speedier versions of some ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Baseline comorbidities did not significantly differ ...

Patients presenting to the emergency department with apparent supraventricular tachycardia (SVT) need prompt follow-up with consideration for screening for atrial fibrillation (AF), especially those ...

The approval was based on data from 5 randomized, double-blind, placebo-controlled trials that included 317 patients with supraventricular tachycardia. Landiolol is a selective beta-1 adrenergic ...